Posts

2020.4 NDA/BLA Inspection Schedule by CFDI for NMPA

 April 2020 NDA/BLA Inspection Schedule by CFDI for NMPA: No. Acceptance number Company Products 1 CXSS1900005  Xinjiang Deyuan Bioengineering Human Immunnglnhlobulin (pH4) for Intravenous Injection 2 CXSS1700033  Shanxi Kangbao Biological Human coagulation factor Ⅷ  3 CYHS1900202  Chongqing Huapont Pharm Aminosalicylate  Enteric-CoatedGranules 4 CXHS1800035  Yichang Humanwell Pharma Ramimazolam Besilate for Injection  5 CXSS1800029  Heibei Daan Pharma  Human Immunnglnhlobulin (pH4) for Intravenous Injection 6 Y20190000075  Chongqing Huapont Kaisheng Pharm Aminosalicylate  7 CYSB1800230  Beijing Kawin Technology  Recombinant Human Interferon α2b Injection  8 CYSB1800229  Beijing Kawin Technology  Recombinant Human Interferon α2b Injection 9 CYSB1800228  Beijing Kawin Technology Recombinant Human Interferon α2b Injection 10 CYSB1800231  Beijing Kawin Technology Recombinant Human Interferon α2b  Vaginal Effervescent Tablets 11 CXSS1900029  Heibei Daan Pharma  Human Prothr